Combinostics at ASNR22

May 16-18, 2022  |  New York, NY
Booth #109

Did you miss our team at ASNR22 or want to discuss our products further? Schedule some time to learn more about how our cNeuro® suite, including the cMRI™ and cDSI™ applications, is a complete AI software solution for entire patient care pathways of major neurological disorders. Our comprehensive suite supports early detection, differentiation of diagnosis, treatment planning and monitoring.

Join us for a presentation at ASNR22.

Tuesday, May 17 | 3:05 pm

Differential diagnosis of dementias: MRI only diagnostic trend to enable differentiation with imaging alone

Presenter: Peter Ngum, Clinical Application Specialist
Location: Rhinelander (2nd Floor)

Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.

Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.

Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests. 

Applications in the cNeuro® suite:

*WIP – not yet cleared for clinical use.
Play Video
Play Video

cDSI

Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.

cMRI

cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.

Play Video